Journal
PURINERGIC SIGNALLING
Volume 11, Issue 4, Pages 411-434Publisher
SPRINGER
DOI: 10.1007/s11302-015-9462-7
Keywords
ADP; Adenosine; Erythrocytes; Platelets; P2Y(1); P2Y(12); P2X(1); Purinoceptor; Thrombosis; Clopidogrel
Categories
Ask authors/readers for more resources
The involvement of purinergic signalling in the physiology of erythrocytes, platelets and leukocytes was recognised early. The release of ATP and the expression of purinoceptors and ectonucleotidases on erythrocytes in health and disease are reviewed. The release of ATP and ADP from platelets and the expression and roles of P1, P2Y(1), P2Y(12) and P2X1 receptors on platelets are described. P2Y(1) and P2X1 receptors mediate changes in platelet shape, while P2Y(12) receptors mediate platelet aggregation. The changes in the role of purinergic signalling in a variety of disease conditions are considered. The successful use of P2Y(12) receptor antagonists, such as clopidogrel and ticagrelor, for the treatment of thrombosis, myocardial infarction and stroke is discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available